Clopidogrel in-laboratory vs. outpatient preloading in chronic coronary syndrome patients undergoing diagnostic coronary angiography with potential ad hoc percutaneous coronary intervention
Open Access
- 29 September 2026
- journal article
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Pharmacotherapy
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- 2024 ESC Guidelines for the management of chronic coronary syndromesEuropean Heart Journal, 2024
- Pretreatment With P2Y12 Inhibitors in Patients With Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the Swedish Coronary Angiography and Angioplasty RegistryCirculation: Cardiovascular Interventions, 2021
- Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary InterventionCirculation, 2019
- Fourth Universal Definition of Myocardial Infarction (2018)JACC, 2018
- 2018 ESC/EACTS Guidelines on myocardial revascularizationEuropean Heart Journal, 2018
- Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus DocumentCirculation, 2018
- Effectiveness of In-Laboratory High-Dose Clopidogrel Loading Versus Routine Pre-Load in Patients Undergoing Percutaneous Coronary InterventionJACC, 2010
- Clopidogrel pre-treatment in stable angina: for all patients >6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI? A randomized multicentre trial PRAGUE-8European Heart Journal, 2008
- Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary InterventionJAMA, 2002